Daptomycin Pore Formation and Stoichiometry Depend on Membrane Potential of Target Membrane.

Antimicrob Agents Chemother

Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic

Published: January 2019

Daptomycin is a calcium-dependent lipodepsipeptide antibiotic clinically used to treat serious infections caused by Gram-positive pathogens. Its precise mode of action is somewhat controversial; the biggest issue is daptomycin pore formation, which we directly investigated here. We first performed a screening experiment using propidium iodide (PI) entry to cells and chose the optimum and therapeutically relevant conditions (10 µg/ml daptomycin and 1.25 mM CaCl) for the subsequent analyses. Using conductance measurements on planar lipid bilayers, we show that daptomycin forms nonuniform oligomeric pores with conductance ranging from 120 pS to 14 nS. The smallest conductance unit is probably a dimer; however, tetramers and pentamers occur in the membrane most frequently. Moreover, daptomycin pore-forming activity is exponentially dependent on the applied membrane voltage. We further analyzed the membrane-permeabilizing activity in cells using fluorescence methods [PI and DiSC(5)]. Daptomycin most rapidly permeabilizes cells with high initial membrane potential and dissipates it within a few minutes. Low initial membrane potential hinders daptomycin pore formation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325215PMC
http://dx.doi.org/10.1128/AAC.01589-18DOI Listing

Publication Analysis

Top Keywords

daptomycin pore
12
pore formation
12
membrane potential
12
daptomycin
8
initial membrane
8
membrane
6
formation stoichiometry
4
stoichiometry depend
4
depend membrane
4
potential target
4

Similar Publications

Article Synopsis
  • The study focuses on the molecular mechanism of gausemycins, which are a class of antibiotics, and details the isolation of new variants named gausemycins C, D, E, and F.
  • It was found that gausemycins A and B exhibit antimicrobial properties that depend on calcium concentrations, requiring more calcium than daptomycin but less than other antibiotics like malacidine.
  • The research confirmed that gausemycins affect bacterial membranes by forming pores, with the ability to do so influenced by the composition of the lipid membranes and calcium levels, as suggested by NMR studies on gausemycin B.
View Article and Find Full Text PDF

Background Local antibiotic applications have been used in chronic osteomyelitis and have been defined as an adjunctive treatment method. Biodegradable materials are also used for the same purpose by adding antibiotics. The fact that it does not require additional surgery to be removed is an important advantage.

View Article and Find Full Text PDF

Daptomycin is a cyclic lipopeptide antibiotic that targets the lipid membrane of Gram-positive bacteria. Membrane fluidity and charge can affect daptomycin activity, but its mechanisms are poorly understood because it is challenging to study daptomycin interactions within lipid bilayers. Here, we combined native mass spectrometry (MS) and fast photochemical oxidation of peptides (FPOP) to study daptomycin-membrane interactions with different lipid bilayer nanodiscs.

View Article and Find Full Text PDF

DAPTOMYCIN, its membrane-active mechanism vs. that of other antimicrobial peptides.

Biochim Biophys Acta Biomembr

October 2020

Department of Physics and Astronomy, Rice University, Houston, TX, USA. Electronic address:

Over 3000 membrane-active antimicrobial peptides (AMPs) have been discovered, but only three of them have been approved by the U.S. Food and Drug Administration (FDA) for therapeutic applications, i.

View Article and Find Full Text PDF

More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin.

Antibiotics (Basel)

January 2020

Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden.

Daptomycin is a cyclic lipopeptide antibiotic, which was discovered in 1987 and entered the market in 2003. To date, it serves as last resort antibiotic to treat complicated skin infections, bacteremia, and right-sided endocarditis caused by Gram-positive pathogens, most prominently methicillin-resistant . Daptomycin was the last representative of a novel antibiotic class that was introduced to the clinic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!